Search research articles
Contact Us
Filters
Showing results (151-160 of 418) with videos related to
Page
of 42
Sort By:
JTO Clinical and Research Reports
|
February 24, 2025
Personalized Therapy in a Patient With <i>EGFR</i>-Mutated NSCLC Developing Sequential <i>CCDC6-RET</i> Fusion and <i>BRAF</i> V600E Mutation as Bypass Resistance Mechanisms
Arianna Marinello, Claudia Parisi, Damien Vasseur, et al.
Journal of Hematology & Oncology
|
October 24, 2024
Predictive value of tumor microenvironment on pathologic response to neoadjuvant chemotherapy in patients with undifferentiated pleomorphic sarcomas
Jean Philippe Guegan, Nathan El Ghazzi, Julien Vibert, et al.
Genes, Chromosomes & Cancer
|
March 4, 2014
Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material
Francois Le Loarer, Lei Zhang, Christopher D Fletcher, et al.
Pediatric Blood & Cancer
|
September 2, 2014
Ewing-like sarcomas with BCOR-CCNB3 fusion transcript: a clinical, radiological and pathological retrospective study from the Société Française des Cancers de L'Enfant
Sarah Cohen-Gogo, Cécile Cellier, Jean-Michel Coindre, et al.
Cancers
|
February 13, 2026
Radiological, Radiomics, and Metastatic Patterns Associated with Targetable Oncogenic Drivers on CT-Scan of Newly Diagnosed NSCLC Patients: A Comprehensive Radiogenomics Review
Letuan Phan, Sophie Cousin, Lou Andrea Sitruk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2023
Upregulation of Indoleamine 2,3-Dioxygenase 1 in Tumor Cells and Tertiary Lymphoid Structures is a Hallmark of Inflamed Non-Small Cell Lung Cancer
Alban Bessede, Florent Peyraud, Sylvestre Le Moulec, et al.
Investigational New Drugs
|
March 9, 2021
A phase 1b study of the Notch inhibitor crenigacestat (LY3039478) in combination with other anticancer target agents (taladegib, LY3023414, or abemaciclib) in patients with advanced or metastatic solid tumors
Analia Azaro, Christophe Massard, William D Tap, et al.
Genes, Chromosomes & Cancer
|
March 3, 2012
The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification
Antoine Italiano, Rachael Thomas, Matthew Breen, et al.
Molecular Cancer
|
February 20, 2024
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide
Maud Toulmonde, Jean-Philippe Guegan, Mariella Spalato-Ceruso, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 25, 2014
A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours
Antoine Hollebecque, Nadine Houédé, Ezra E W Cohen, et al.
Page
of 42
Search research articles
Search
Showing results (151-160 of 418) with videos related to
Sort By:
Page
of 42
JTO Clinical and Research Reports
|
February 24, 2025
Personalized Therapy in a Patient With <i>EGFR</i>-Mutated NSCLC Developing Sequential <i>CCDC6-RET</i> Fusion and <i>BRAF</i> V600E Mutation as Bypass Resistance Mechanisms
Arianna Marinello, Claudia Parisi, Damien Vasseur, et al.
Journal of Hematology & Oncology
|
October 24, 2024
Predictive value of tumor microenvironment on pathologic response to neoadjuvant chemotherapy in patients with undifferentiated pleomorphic sarcomas
Jean Philippe Guegan, Nathan El Ghazzi, Julien Vibert, et al.
Genes, Chromosomes & Cancer
|
March 4, 2014
Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material
Francois Le Loarer, Lei Zhang, Christopher D Fletcher, et al.
Pediatric Blood & Cancer
|
September 2, 2014
Ewing-like sarcomas with BCOR-CCNB3 fusion transcript: a clinical, radiological and pathological retrospective study from the Société Française des Cancers de L'Enfant
Sarah Cohen-Gogo, Cécile Cellier, Jean-Michel Coindre, et al.
Cancers
|
February 13, 2026
Radiological, Radiomics, and Metastatic Patterns Associated with Targetable Oncogenic Drivers on CT-Scan of Newly Diagnosed NSCLC Patients: A Comprehensive Radiogenomics Review
Letuan Phan, Sophie Cousin, Lou Andrea Sitruk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2023
Upregulation of Indoleamine 2,3-Dioxygenase 1 in Tumor Cells and Tertiary Lymphoid Structures is a Hallmark of Inflamed Non-Small Cell Lung Cancer
Alban Bessede, Florent Peyraud, Sylvestre Le Moulec, et al.
Investigational New Drugs
|
March 9, 2021
A phase 1b study of the Notch inhibitor crenigacestat (LY3039478) in combination with other anticancer target agents (taladegib, LY3023414, or abemaciclib) in patients with advanced or metastatic solid tumors
Analia Azaro, Christophe Massard, William D Tap, et al.
Genes, Chromosomes & Cancer
|
March 3, 2012
The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification
Antoine Italiano, Rachael Thomas, Matthew Breen, et al.
Molecular Cancer
|
February 20, 2024
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide
Maud Toulmonde, Jean-Philippe Guegan, Mariella Spalato-Ceruso, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 25, 2014
A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours
Antoine Hollebecque, Nadine Houédé, Ezra E W Cohen, et al.
Page
of 42